Botulinum toxin shows promise in trials to reduce post-operative atrial fibrillation (POAF) in cardiac surgery patients

Postoperative atrial fibrillation (POAF) is a common complication, affecting one quarter to one half of all patients following cardiac surgery. It can result in heart failure, stroke, and longer hospital stays, resulting in an increased cost of care. A new study reports promising results from two clinical trials using botulinum toxin (BTX) injections to suppress POAF.

from Health & Medicine News -- ScienceDaily https://ift.tt/2rav5Fm

Comments

Popular posts from this blog

New 3D imaging and visualization technique provides detailed views of muscle architecture